China Health-Care Shares Plunge as Anti-Graft Campaign Widens
- At least 155 officials at hospitals are being probed: report
- Crackdown may lead to increased volatility: Straits Investment
This article is for subscribers only.
China’s health-care stocks slumped as sentiment took a hit after authorities widened an anti-graft crackdown on the sector.
The CSI 300 Health Care Index declined as much as 3.4% on Monday to underperform all the other sectors on the onshore benchmark gauge. The biggest losers included Huadong Medicine Co. and Shenzhen Mindray Bio-Medical Electronics Co.